InsidersTradesSigma
Discover the full record of transactions filed by Rovaldi Christopher, Executive. Officer active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 2 filings have been published. History available since 1 April 2022. The latest transaction was disclosed on 6 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Christopher Rovaldi is the Chief Operating Officer of Keros Therapeutics, Inc. In this role, he oversees the company's operations and ensures process efficiency. His expertise is essential for the smooth functioning of the organization.